Biothera Competitors and Similar CompaniesClear all
Biothera's competitors and similar companies include Aceragen, Akebia Therapeutics, AKESOgen and Novartis Gene Therapies.
 Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. |  Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. |  AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural |  Novartis Gene Therapies Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases. | ||
Founding Date | Founding Date 1997 | Founding Date 1989 | Founding Date 2007 | Founding Date 2010 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Roseville, US HQ | Locations Durham, US HQ | Locations Cambridge, US HQ | Locations Norcross, US HQ | Locations Bannockburn, US HQ |
Employees | Employees 542% increase | Employees 3642% decrease | Employees 324187% increase | Employees 6 | Employees 6603% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.2 m | Valuation ($) 359.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $4.9m (FY, 2022) | Revenue (est.) $236.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($23.4m) (FY, 2022) | Net income ($5.3m) (FY, 2025) | Net income N/A | Net income ($218.1m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 5.1m | Total funding raised $ 13.8m | Total funding raised N/A | Total funding raised $ 1.5m | Total funding raised $ 75m |
For sources of this data, please see the company profile
View Company Profiles
Aceragen
HQ
Durham, US
Employees
36↓ 42% decrease
Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View companyAKESOgen
HQ
Norcross, US
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
View companyNovartis Gene Therapies
HQ
Bannockburn, US
Novartis Gene Therapies (formerly known as AveXis) is a biotech company developing innovative treatments for rare and life-threatening genetic diseases.
View company